Vardenafil (Levitra/Staxyn) Cost in Colorado: 2026 Pricing, Insurance, and Savings Guide

What Vardenafil Costs at Colorado Pharmacies in 2026

The price you pay for vardenafil in Colorado depends on whether you fill brand Levitra, a generic tablet, or the Staxyn orally disintegrating formulation. Bayer's list price for brand Levitra remains approximately $350 per month for a supply of eight 20 mg tablets. Generic vardenafil, available since patent expiration, averages around $120 per month at Colorado retail pharmacies when paying cash without insurance.

Price variation across the state is significant. A 2024 JAMA analysis of pharmacy-level pricing found that cash prices for the same generic drug can differ by 200% to 800% between pharmacies within a single metropolitan area [1]. Denver-metro pharmacies often price generics more competitively than rural Colorado locations due to higher competition among chains. Costco, Walmart, and independent pharmacies in Colorado Springs, Fort Collins, and Boulder tend to cluster near the $90 to $130 range for a month's supply of generic vardenafil 20 mg (eight tablets).

Staxyn, the orally disintegrating tablet formulation, carries a separate pricing structure. Because Staxyn uses a different delivery system and is not AB-rated as interchangeable with standard vardenafil tablets [2], no true generic equivalent exists for the ODT form. Cash prices for Staxyn typically exceed brand Levitra.

The FDA approved vardenafil in 2003 as the second PDE5 inhibitor after sildenafil [3]. Porst et al. demonstrated in a key trial (N=601) that vardenafil 20 mg improved erectile function domain scores from 13.3 to 22.0 on the IIEF, compared to 14.7 for placebo [4]. That efficacy profile supports its continued prescribing despite the availability of newer alternatives.

Generic Vardenafil vs. Brand Levitra: The Price Gap

Generic vardenafil saves Colorado patients roughly 60% to 70% compared to brand Levitra. The savings are straightforward. Brand Levitra lists near $350 per month, while generic vardenafil averages $120 at cash pay. For patients filling quarterly, that difference adds up to nearly $700 in savings over three months.

Multiple manufacturers produce generic vardenafil tablets in 5 mg, 10 mg, and 20 mg strengths. The FDA's Orange Book confirms therapeutic equivalence (AB rating) between approved generics and brand Levitra tablets [5]. Bioequivalence standards require that generic formulations deliver 80% to 125% of the reference drug's AUC and Cmax, a window that the FDA considers clinically identical [6].

Tablet splitting is a common cost-reduction strategy. A patient prescribed 10 mg can purchase 20 mg tablets and split them, effectively halving the per-dose cost. The American Urological Association does not specifically endorse or discourage this practice for PDE5 inhibitors, but the scored tablet design of most generic vardenafil formulations makes it feasible [7]. Patients should confirm with their pharmacist that their specific generic is scored.

One caveat: Staxyn ODT tablets must not be split. The orally disintegrating formulation has different pharmacokinetics than standard tablets, reaching peak plasma concentration faster [2]. Splitting would destroy the ODT matrix and alter absorption.

Colorado Medicaid and Vardenafil Coverage

Colorado Medicaid does not cover vardenafil for erectile dysfunction. This exclusion is consistent with the federal Medicaid Drug Rebate Program's allowance for states to exclude drugs used for erectile dysfunction from their preferred drug lists [8]. Colorado's Health First Colorado formulary lists ED medications as a non-covered benefit category for standard adult Medicaid recipients.

There is a narrow exception. Vardenafil carries an FDA-recognized indication for erectile dysfunction only [3], but some state Medicaid programs have covered PDE5 inhibitors when prescribed for pulmonary arterial hypertension (PAH). In Colorado, sildenafil (as Revatio) and tadalafil (as Adcirca) hold PAH-specific approvals, while vardenafil does not. Patients seeking Medicaid coverage of a PDE5 inhibitor for PAH would need one of those alternatives.

For Medicaid recipients who need ED treatment, the out-of-pocket burden falls entirely on the patient. Options include compounded vardenafil through 503A pharmacies, manufacturer assistance, or discount card programs. The Centers for Medicare and Medicaid Services issued guidance in 2023 reaffirming that states are not required to cover any ED drug class under Medicaid [9].

Medicare Part D and Commercial Insurance in Colorado

Medicare Part D plans in Colorado vary widely in their vardenafil coverage. The Medicare Modernization Act of 2003 originally excluded ED drugs from Part D formularies, but Congress reversed that exclusion effective 2007 for certain plans [10]. Today, most Part D plans that include ED medications require prior authorization and impose quantity limits, typically six to eight tablets per month.

Commercial insurance coverage follows a similar pattern. Large Colorado employers and exchange plans through Connect for Health Colorado may include generic vardenafil on Tier 2 or Tier 3, with copays ranging from $30 to $75 per fill. UnitedHealthcare, Cigna, Anthem (now Elevance Health), and Kaiser Permanente Colorado each maintain distinct formulary positions for PDE5 inhibitors.

Prior authorization criteria typically require documentation of erectile dysfunction diagnosis, a trial-and-failure or contraindication to sildenafil (the lowest-cost PDE5 inhibitor), and absence of contraindicated nitrate use. The American Urological Association's 2018 guideline on ED management recommends PDE5 inhibitors as first-line pharmacotherapy [7], which supports medical necessity arguments during the PA process.

"PDE5 inhibitors remain the recommended first-line treatment for erectile dysfunction, and choice among agents should consider patient preference, cost, and side-effect profile," states the AUA guideline panel [7].

Patients with high-deductible health plans face the full cash price until meeting their deductible. In these situations, filling at a pharmacy that accepts discount cards or switching to compounded vardenafil can reduce the financial burden during the deductible phase.

Compounded Vardenafil in Colorado: Legality and Pricing

Compounded vardenafil is legal in Colorado through licensed 503A pharmacies. Section 503A of the Federal Food, Drug, and Cosmetic Act permits licensed pharmacies to compound medications based on individual patient prescriptions, provided the pharmacy meets state board of pharmacy requirements [11]. The Colorado State Board of Pharmacy oversees 503A compounding within state lines.

A 503A pharmacy can prepare vardenafil in standard oral tablet or capsule forms, as well as alternative formulations such as sublingual troches or combination compounds (vardenafil with tadalafil, for example). Pricing from Colorado-based or Colorado-shipping 503A pharmacies typically undercuts retail generic pricing, sometimes substantially.

The distinction between 503A and 503B matters. Section 503B outsourcing facilities operate under FDA oversight and can produce compounded drugs without patient-specific prescriptions, distributing in larger quantities to healthcare providers [12]. Colorado telehealth platforms that ship compounded ED medications typically source from 503B-registered outsourcing facilities, which adds a layer of federal quality oversight.

Patients should verify that any compounding pharmacy holds an active license with the Colorado Department of Regulatory Agencies (DORA). The Colorado Board of Pharmacy publishes a searchable license verification database. Out-of-state pharmacies shipping compounded vardenafil into Colorado must also hold a Colorado non-resident pharmacy license.

Quality is the primary consideration. The FDA has issued multiple warning letters to compounding pharmacies for sterility violations and potency failures [11]. Patients should ask their compounding pharmacy about third-party potency testing and whether the facility has passed its most recent state board inspection without citations.

Telehealth Prescribing of Vardenafil in Colorado

Colorado permits telehealth prescribing of vardenafil without an in-person visit. The Colorado Medical Practice Act, updated through multiple legislative sessions, authorizes physicians and advanced practice providers to prescribe medications via synchronous telehealth encounters [13]. No separate in-person visit is required for an ED diagnosis when the provider determines the telehealth evaluation is clinically sufficient.

The Ryan Haight Online Pharmacy Consumer Protection Act requires a valid prescription for controlled substances dispensed online, but vardenafil is not a controlled substance [14]. This means telehealth platforms can prescribe and ship vardenafil to Colorado addresses without the DEA registration requirements that apply to controlled substances.

Multiple telehealth platforms serve Colorado patients for ED prescriptions. HealthRX provides physician-supervised telehealth evaluations, with prescriptions for generic or compounded vardenafil filled through licensed pharmacies. The process typically involves a health questionnaire, provider review, and prescription issuance within 24 to 48 hours.

A 2021 study in the Journal of Sexual Medicine found that telehealth-based ED prescribing increased 20-fold during the COVID-19 pandemic, with patient satisfaction rates exceeding 85% [15]. The convenience factor is especially relevant for Colorado's rural communities, where the nearest urologist may be hours away. Colorado has approximately 3.2 urologists per 100,000 population, below the national average of 3.8, according to AUA workforce data [7].

Savings Strategies: Discount Cards, Coupons, and Programs

Several pathways exist for reducing vardenafil costs in Colorado beyond insurance. Discount card programs such as GoodRx, RxSaver, and SingleCare negotiate contracted rates with participating pharmacies. These programs can bring generic vardenafil below $100 per month at select Colorado pharmacies, particularly warehouse clubs and large chains.

Bayer historically offered a Levitra savings card for commercially insured patients, reducing copays on brand Levitra. Availability of brand-specific programs fluctuates. Patients should check directly with Bayer's patient assistance portal or call the number on the Levitra prescribing information for current program status [2].

For uninsured patients, the NeedyMeds database and RxAssist catalog patient assistance programs by drug name. Generic manufacturers occasionally offer their own discount programs, though these are less common for high-volume generics like vardenafil [16].

"The cost of ED medications should not be a barrier to treatment. Clinicians should discuss pricing openly and help patients identify the most affordable option," notes Dr. Arthur Burnett, former president of the Sexual Medicine Society of North America, in a 2022 commentary [17].

Pill splitting, as discussed above, remains one of the most effective and immediate savings strategies. A patient prescribed 10 mg who purchases 20 mg tablets and splits them can reduce their per-dose cost by approximately 40% to 50%, since 20 mg tablets rarely cost twice as much as 10 mg tablets.

How Vardenafil Compares to Other PDE5 Inhibitors on Cost

Choosing a PDE5 inhibitor in Colorado often comes down to formulary placement and out-of-pocket cost rather than efficacy differences. A 2019 Cochrane systematic review of 82 trials (N=47,626) found no significant differences in overall efficacy among sildenafil, tadalafil, vardenafil, and avanafil for ED treatment [18]. The choice is typically driven by onset speed, duration of action, side-effect profile, and price.

Generic sildenafil is the lowest-cost PDE5 inhibitor in Colorado, averaging $20 to $40 per month for a comparable supply. Generic tadalafil falls in the $30 to $60 range. Vardenafil at $120 per month sits higher, though compounded pricing narrows that gap. Avanafil (Stendra) remains the most expensive, with limited generic availability.

Vardenafil's pharmacokinetic profile offers a distinct niche. It reaches peak plasma concentration in 0.7 to 0.9 hours, with a half-life of 4 to 5 hours [2]. Tadalafil's 17.5-hour half-life suits patients who prefer a longer window. A head-to-head crossover trial by Rubio-Aurioles et al. (2006) found that patients were evenly split in preference between vardenafil and sildenafil, with vardenafil showing a slight advantage in time to onset by patient report [19].

For patients in Colorado whose insurance formulary places sildenafil at Tier 1 and vardenafil at Tier 3, the cost difference may steer the initial choice. However, the AUA guideline recommends trying an alternative PDE5 inhibitor if the first is ineffective or poorly tolerated [7], which provides medical justification for vardenafil coverage even when it is not formulary-preferred.

Safety Considerations That Affect Cost Decisions

Vardenafil's safety profile can influence total cost of treatment through dose adjustments and monitoring requirements. The prescribing information contraindicates vardenafil with nitrates and alpha-blockers (with specific exceptions for tamsulosin at stable dose) [2]. Patients taking nitrates for angina cannot use any PDE5 inhibitor and require alternative ED treatments, which often carry higher costs.

Dose-dependent side effects include headache (15%), flushing (11%), rhinitis (9%), and dyspepsia (4%) at the 20 mg dose in key trials [4]. QT prolongation is a vardenafil-specific concern among PDE5 inhibitors. The FDA label notes that vardenafil 10 mg increased QTc by 8 ms compared to placebo [2]. Patients with congenital long QT syndrome or those taking Class IA or III antiarrhythmics should not use vardenafil.

This QT signal means some patients require a baseline ECG before starting vardenafil, adding $50 to $150 to the initial treatment cost depending on insurance status. The 2018 AUA guideline does not mandate routine ECG for all PDE5 inhibitor initiations but notes that cardiovascular risk assessment is appropriate [7].

Hepatic impairment requires dose reduction. Patients with moderate hepatic dysfunction (Child-Pugh B) should start at 5 mg, and vardenafil is not recommended in severe hepatic impairment [2]. Renal impairment does not require dose adjustment for creatinine clearance above 30 mL/min, but patients on hemodialysis should start at 5 mg [2].

Age-related pharmacokinetic changes are relevant to Colorado's population. Adults 65 and older show approximately 52% higher vardenafil AUC compared to younger adults, leading to a recommended starting dose of 5 mg [2]. Starting at 5 mg rather than 10 mg effectively halves the per-dose cost if using pill splitting from 10 mg tablets.